{"Symbol": "PFE", "AssetType": "Common Stock", "Name": "Pfizer Inc", "Description": "Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.", "CIK": "78003", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "235 E 42ND ST, NEW YORK, NY, US", "OfficialSite": "https://www.pfizer.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "127777776000", "EBITDA": "23321999000", "PERatio": "15.98", "PEGRatio": "0.536", "BookValue": "15.56", "DividendPerShare": "1.68", "DividendYield": "0.0763", "EPS": "1.41", "RevenuePerShareTTM": "11.23", "ProfitMargin": "0.126", "OperatingMarginTTM": "0.159", "ReturnOnAssetsTTM": "0.0464", "ReturnOnEquityTTM": "0.0906", "RevenueTTM": "63627002000", "GrossProfitTTM": "47206998000", "DilutedEPSTTM": "1.41", "QuarterlyEarningsGrowthYOY": "-0.982", "QuarterlyRevenueGrowthYOY": "0.219", "AnalystTargetPrice": "29.43", "AnalystRatingStrongBuy": "3", "AnalystRatingBuy": "6", "AnalystRatingHold": "13", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "0", "TrailingPE": "15.98", "ForwardPE": "7.66", "PriceToSalesRatioTTM": "2.008", "PriceToBookRatio": "1.449", "EVToRevenue": "2.687", "EVToEBITDA": "9.43", "Beta": "0.597", "52WeekHigh": "30.55", "52WeekLow": "20.91", "50DayMovingAverage": "24.97", "200DayMovingAverage": "27.15", "SharesOutstanding": "5671450000", "DividendDate": "2025-03-07", "ExDividendDate": "2025-01-24"}